🇺🇸 FDA
Patent

US 10533186

Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

granted A61KA61K2039/5254A61K39/12

Quick answer

US patent 10533186 (Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/5254, A61K39/12, A61P, A61P31/12